Definition
Infrared LED (Light Emitting Diode, 600-1000nm) is a skin tightening technology based on photobiomodulation, a cellular activation mechanism through exposure to light at specific wavelengths. Unlike HIFU (thermal mechanism via ultrasound) and radiofrequency (thermal mechanism via electromagnetism), infrared LED works primarily without notable skin temperature elevation. Photonic energy is absorbed by intracellular chromophores, notably mitochondrial cytochrome c oxidase, activating the electron transport chain and increasing ATP (adenosine triphosphate) production. This increase in cellular energy stimulates fibroblasts to synthesize collagen, progressively improving skin elasticity and tone. Infrared LED offers a gentle approach, suitable for sensitive skin, with zero downtime and cumulative effect over repeated protocols.
Physical principles: photons and light spectra
Infrared LED emits photons at specific wavelengths depending on the semiconductor composition used. Wavelengths used in aesthetics include:
Visible red LED (600-700nm, typically 630nm): moderate penetration (4-10mm), notable absorption by hemoglobin and carotenoids, moderate collagen stimulation, vascular effect.
Near-infrared LED (700-900nm, typically 808nm): intermediate penetration (6-12mm), optimal absorption by mitochondrial cytochrome c oxidase, strong collagen stimulation, low hemoglobin absorption.
Far-infrared LED (900-1100nm, typically 1000nm): deep penetration (12-20mm), moderate cytochrome c absorption, maximum tissue penetration but reduced surface intensity.
In aesthetics, 630nm and 808nm LEDs are the most commonly used. Each photon carries energy E = hf = hc/lambda, where h is Planck's constant (6.62 x 10^-34 J.s), f is frequency, c is the speed of light (3 x 10^8 m/s), lambda is wavelength. A 630nm photon carries approximately 3.1 eV energy; an 808nm photon carries approximately 1.5 eV. These energies are sufficient to excite electronic states of chromophores but insufficient for ionization (ionization energy approximately 13 eV for hydrogen atom). This is why photobiomodulation is generally safe and non-ionizing.
The LED device contains a matrix of emitting diodes covering the treatment zone (face, body). Typical power density: 10-100 mW/cm² (well below laser, which can exceed 1000 mW/cm²). Exposure duration: 10-30 minutes per session to accumulate effective fluence (50-200 J/cm²).
Biological mechanism: the mitochondrial pathway
LED photobiomodulation works via a well-documented cellular pathway, the mitochondrial ATP pathway:
ABSORPTION BY CYTOCHROME C OXIDASE
near-infrared photons (600-1000nm) are absorbed by cytochrome c oxidase (Complex IV), an enzyme in the mitochondrial electron transport chain. This protein complex contains hemes and copper (infrared-absorbing chromophores) and catalyzes the final electron transfer to oxygen, generating the proton gradient that drives ATP synthase.
ELECTRONIC EXCITATION
photon absorption elevates cytochrome c oxidase electrons to higher energy states. This excitation improves electron transfer efficiency, enhancing proton flux across the inner mitochondrial membrane.
MEMBRANE POTENTIAL INCREASE
improved electron flux amplifies the transmembrane proton gradient (electrical voltage across the membrane). This accumulated potential drives ATP synthase.
ATP PRODUCTION
ATP synthase uses the proton gradient energy to phosphorylate ADP into ATP. Result: 10-40% increase in intramitochondrial ATP production above baseline.
FIBROBLAST ACTIVATION
fibroblasts, the skin stromal cells responsible for collagen synthesis, are extremely ATP-dependent for their functions: protein synthesis, collagen secretion, cellular migration. Increased available ATP stimulates fibroblasts to enter a high-synthesis state: increased pro-collagen mRNA, increased protein translation, secretion of new collagen.
PARACRINE AMPLIFICATION
stimulated fibroblasts also secrete cytokines (bFGF, TGF-beta) that stimulate neighboring fibroblasts via paracrine signaling, amplifying the initial effect.
DE NOVO COLLAGEN SYNTHESIS
synthesis begins 24-48h post-treatment, amplifies over 2-4 weeks, with collagen maturation over 8-12 weeks. Unlike RF/HIFU which induce denaturation + repair (microinjury model), LED induces direct metabolic augmentation without primary damage.
This metabolic activation mechanism (rather than damage-repair) explains LED's superior safety profile: no burns, no pain, no downtime, universal tolerance. However, the magnitude of collagen stimulation is less pronounced than RF/HIFU (gain approximately 30-50% vs approximately 60-80%), requiring longer protocols (10-20 sessions).
Clinical applications of LED photobiomodulation
Infrared LED addresses several aesthetic indications:
Skin revitalization
patients with atonic, dull skin lacking radiance. LED stimulates global fibroblast metabolism, producing visible texture and luminosity improvement at 4-6 weeks.
Mild-to-moderate tightening
very slight skin laxity (early 30-40s), candidates not appropriate for RF/HIFU. LED provides acceptable gradual tightening.
Post-treatment sensitive skin
patients who have had ablative laser, chemical peeling, or other aggressive treatments. Non-irritating LED allows post-treatment revitalization without complication risk.
Photo-aging prevention as maintenance
prophylactic anti-aging for young patients (20-30s) seeking to delay skin aging. Maintenance protocols 1-2 times/month.
Post-inflammatory scars
LED stimulates fibroblasts, promotes collagen remodeling and can attenuate mild atrophic scars. Modest effect but synergistic with other modalities.
Acne and post-acne
630nm (red) LED has documented anti-bacterial activity (bacterial porphyrin absorption), though moderate efficacy vs blue light or laser. Useful for post-acne treatment maintenance.
Cellulite adjuvant treatment
LED alone is ineffective for moderate-to-severe cellulite, but as an adjuvant to RF/cavitation/vacuum can improve results through additional collagen stimulation.
Contraindications are very rare: extreme photosensitivity (porphyria cutanea tarda, xeroderma pigmentosum), malignant skin tumors (theoretical potential vascular stimulation, limited data). In general, infrared LED is very well tolerated.
Clinical efficacy data
The scientific literature on LED photobiomodulation has exploded in the last decade, documenting efficacy across multiple indications:
AVCI ET AL. (Semin Cutan Med Surg 2013): meta-analysis of 69 photobiomodulation studies. Conclusion: strong evidence (level A) for in vitro and in vivo collagen stimulation, scar improvement, dermatitis. Moderate evidence for anti-aging and skin tightening.
WUNSCH & MATUSCHKA (2014): infrared photobiomodulation review. Documented efficacy for: wound healing (20-30% acceleration), anti-inflammatory (30-50% reduction), muscle pain and arthritis. Aesthetic skin data limited but consistent with collagen stimulation.
BAROLET (2008): photobiomodulation and vascular neogenesis. Infrared LED stimulates angiogenesis (VEGF pathway) beyond simple fibroblast stimulation. Vascular improvement contributes to observed complexion improvement.
SPECIFIC COSMETIC STUDIES: reported LED 630-808nm efficacy:
- Skin texture improvement: 40-60% of patients report visible improvement
- Superficial wrinkle improvement: 30-50% reduction measured in vivo
- Firmness/lift improvement: 25-40% subjective improvement
- Timeline: visible results at 4-6 weeks, peak at 8-12 weeks
- Effect duration: 3-6 months, then progressive degradation
COMPARISON WITH RF/HIFU: LED efficacy is 50% lower than RF/HIFU for pure tightening, but safety and tolerance profile is significantly superior. LED is ideal for anti-aging maintenance and global revitalization; RF/HIFU for clinically significant skin laxity.
COMBINATORY POTENTIAL: preliminary studies suggest LED + RF synergy: RF for rapid heating + TCP creation + inflammation stimulation; LED for post-RF fibroblast metabolic amplification. Combined protocols show 15-25% additional improvement vs RF alone.
Frequently asked questions
HIFU creates thermal coagulation points at 65-75°C at precise depth, immediate effect + progressive neocollagenesis. RF heats tissue diffusely to 40-45°C, immediate contraction + neocollagenesis over 6-10 sessions. LED stimulates mitochondrial ATP metabolism without heat, gradual neocollagenesis over 10-20 sessions, zero downtime. Efficacy: HIFU > RF > LED. Safety/tolerance: LED > RF > HIFU. Choice depends on laxity severity and downtime preference.
Standard protocol: 10-20 sessions 2-3 times/week. Short interval (48-72h) allows dose stimulation accumulation. Visible results: 4-6 weeks (after 8-12 sessions). Peak improvement: 8-12 weeks. Maintenance: 1-2 sessions/month for sustained effect. Total protocol duration: 8-12 weeks for initiation, then perpetual maintenance.
No sensation during treatment. Mild superficial warming possible if intense and prolonged light (> 20min) but no pain. Patient can nap during the session. Post-treatment: no redness, no edema, no restrictions. Eye safety: protective glasses recommended but not mandatory (non-ionizing infrared, no documented retinal risk).
Yes, LED is compatible with nearly everything: botulinum toxin, fillers, non-ablative laser, RF, HIFU. No negative interaction. LED + RF: optimal synergy (space at least 24h apart). LED post-laser: safe revitalization. LED pre-surgery: beneficial skin preparation. Combined protocols can increase overall results by 15-25%.
Risks are near zero. Extremely rare adverse effects: mild headache (light in eyes), contact pad allergy (very rare). True contraindication: extreme photosensitivity (porphyria). Relative: malignant skin tumor (insufficient data, avoid tumor area). Pregnancy: limited safety data, avoid as precaution. In general, infrared LED is very safe for all phototypes.
Several reasons: (1) LED efficacy is slightly lower, (2) long protocols (10-20 sessions vs 1-3 HIFU), (3) subtle results (30-50% vs 60-80%), (4) marketing: RF/HIFU generate an immediate 'wow', LED results are gradual and less spectacular, (5) device costs and patient time. LED excels for maintenance and revitalization; RF/HIFU for definitive correction. Trend: hybrid LED + RF/HIFU approach is optimal.
Sources scientifiques
- Avci P et al.. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg (2013) ;32 (1) :41-52 . PMID: 24049929
- Wunsch A, Matuschka K. A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction. Photomed Laser Surg (2014) ;32 (2) :93-100 . PMID: 24286286
- Desmet KD et al.. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg (2006) ;24 (2) :121-128 . PMID: 16706694
- Barolet D. Light-emitting diodes (LEDs): Applied clinical practice. J Cosmet Dermatol (2008) ;7 (1) :71-77 . PMID: 18254810
- Hamblin MR, Demidova TN. Mechanisms of low level light therapy. Photomed Laser Surg (2006) ;24 (2) :121-128 . PMID: 16706694
Vous souhaitez en savoir plus ?
Contactez nos experts pour une démonstration personnalisée des appareils NeoCure.
Demander une démonstration